Form 4: RA Capital Management Discloses Septerna Stock Option

RA Capital Management, L.P. and affiliated entities have reported the acquisition of a stock option for 15,000 shares of Septerna, Inc. (SEPN) common stock.

Summary

• RA Capital Management, L.P., along with its associated funds RA Capital Healthcare Fund, L.P. and RA Capital Nexus Fund III, L.P., has filed a Form 4 statement with the SEC.
• The filing details the acquisition of a stock option to purchase 15,000 shares of Septerna, Inc. (SEPN) common stock.
• The option has an exercise price of $37.34 per share and an expiration date of June 25, 2036.
• The underlying shares are subject to vesting conditions tied to the Issuer's next annual meeting or June 26, 2027, contingent on continued service.
• Key individuals associated with RA Capital, including Peter Kolchinsky and Rajeev Shah, are listed as reporting persons, along with Dr. Jake Simson, a Partner at RA Capital Management, who serves on Septerna's board.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it indicates continued interest and potential upside from a major investor, but it does not provide new financial performance data.

Positives

• RA Capital Management, a significant investor, has acquired a stock option, indicating a potential long-term interest in Septerna's performance.
• The option's exercise price of $37.34 suggests a belief in the company's ability to reach or exceed this valuation.
• The involvement of Dr. Jake Simson on Septerna's board, coupled with RA Capital's investment, suggests a strategic alignment and potential for active engagement.

Negatives

• The filing is a Form 4, which reports changes in beneficial ownership and does not inherently contain financial performance data or operational updates.
• The option is held for the benefit of RA Capital funds, and Dr. Simson is obligated to turn over any net proceeds, meaning RA Capital entities disclaim direct beneficial ownership of the option and underlying stock, except for their pecuniary interest.

Risks

• The vesting of the stock option is contingent on Dr. Simson's continued service to Septerna, introducing a potential risk if his service is terminated.
• The value of the stock option is directly tied to the future stock price performance of Septerna, Inc., which is subject to market volatility and company-specific risks.

Future Outlook

The acquisition of a stock option by RA Capital Management suggests a positive outlook on Septerna's future stock performance, as the option's value is directly linked to the stock price exceeding the exercise price.

Management Comments

• RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund III, L.P. (the "Nexus Fund III").
• The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members.
• Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund III, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.
• Under Dr. Simson's arrangement with the Adviser, Dr. Simson holds the option for the benefit of the Fund and the Nexus Fund III.
• Dr. Simson is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option, which will offset advisory fees owed by the Fund and the Nexus Fund III to the Adviser.
• The Reporting Persons therefore disclaim beneficial ownership of the option and underlying common stock.
• Dr. Jake Simson, a Partner of the Adviser, serves on the Issuer's board of directors.

Industry Context

StockSavvy.ai notes that Form 4 filings by significant investment firms like RA Capital Management often signal strategic interest and potential for active involvement in portfolio companies, particularly in the biotechnology and healthcare sectors where RA Capital is a prominent investor.

Related Party Transactions

• Dr. Jake Simson, a Partner of RA Capital Management, serves on Septerna's board of directors.
• Dr. Simson holds the stock option for the benefit of RA Capital funds, and any proceeds from exercising the option will offset advisory fees owed by these funds to RA Capital Management.

Stakeholder Impact

• Shareholders: The filing indicates continued strategic interest from a significant investor, which could be viewed positively, but the option itself does not immediately impact share count or value.
• Employees: The continued service of Dr. Simson, a key figure in RA Capital, on the board may imply a stable strategic direction.
• Creditors: No direct impact is indicated.

Next Steps

• The stock option may be exercised by RA Capital entities if Septerna's stock price exceeds $37.34 and vesting conditions are met.
• Continued service of Dr. Jake Simson on Septerna's board is a condition for option vesting.

Key Dates

Keywords

Form 4, SEC Filing, RA Capital Management, Septerna Inc., SEPN, Stock Option, Beneficial Ownership, Insider Trading, Peter Kolchinsky, Rajeev Shah, Jake Simson